medigraphic.com
ISSN 1561-2929 (Print)

2019, Number 1

<< Back Next >>

RCAN 2019; 29 (1)

Consumo de alimentos, estilos de vida y estado nutricional de los pacientes infectados con VIH que son atendidos en un hospital de especialidades de la ciudad de Guayaquil

González GWA, Mazacón GMN, Burgos GE

Language: Spanish
References: 53
Page: 47-63
PDF size: 708.42 Kb.


ABSTRACT

No Abstract.


REFERENCES

  1. Piot P, Bartos M, Ghys PD, Walker N, Schwartländer B. The global impact of HIV/AIDS. Nature 2001; 410(6831): 968-734.

  2. Gayle HD, Hill GL. Global impact of human immunodeficiency virus and AIDS. Clin Microbiol Rev 2001;14: 327-35.

  3. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-21.

  4. Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: Epidemiology and strategies for prevention. Tubercle Lung Dis 1992;73:311-21.

  5. Armstrong-James D, Meintjes G, Brown GD. A neglected epidemic: Fungal infections in HIV/AIDS. Trends Microbiol 2014;22:120-7.

  6. Hogg RS, O'Shaughnessy MV, Gataric N, Yip B, Craib K, Schechter MT, Montaner JS. Decline in deaths from AIDS due to new antiretrovirals. The Lancet 1997;349(9061):1294.

  7. Broder S. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res 2010;85:1-18.

  8. Palella Jr FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT; et al; for the HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. JAIDS J Acquir Imm Def Synd 2006;43:27-34.

  9. Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM; et al; for the Triservice AIDS Clinical Consortium. Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. JAIDS J Acquir Imm Def Synd 2006;41:194-200.

  10. Robbins KE, Lemey P, Pybus OG, Jaffe HW, Youngpairoj AS, Brown TM.; et al. US Human immunodeficiency virus type 1 epidemic: Date of origin, population history, and characterization of early strains. J Virol 2003;77:6359-66.

  11. Montagnier L. 25 years after HIV discovery: Prospects for cure and vaccine. Virology 2010;397:248-54.

  12. Gallo RC. The early years of HIV/AIDS. Science 2002;298(5599):1728-30.

  13. Kilmarx PH. Global epidemiology of HIV. Curr Opin HIV AIDS 2009;4: 240-6.

  14. UNAIDS/ONUSIDA. Report on the global AIDS epidemic, 2010. Disponible en: http://www.unaids.org/globalreport/Global_report.htm. Fecha de última visita: 12 de Febrero del 2018.

  15. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. The Lancet 2006;368(9534):489-504.

  16. Fettig J, Swaminathan M, Murrill CS, Kaplan JE. Global epidemiology of HIV. Infect Dis Clin 2014;28:323-37.

  17. Teva I, Bermúdez M, Ramiro MT, Buela-Casal G. Situación epidemiológica actual del VIH/SIDA en Latinoamérica en la primera década del siglo XXI: Análisis de las diferencias entre países. Rev Méd Chile 2012;140:50-8.

  18. Thiébaut R, Malvy D, Marimoutou C, Davis F; for the Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA). Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Eur J Epidemiol 2000;16:633-9.

  19. Linares Guerra EM, Santana Porbén S, Carrillo Fornés O, Sánchez L, Amparo M, Sanabria Negrín JG; et al. Estadonutricional de las personas con VIH/Sida; su relación con el conteo de las células T CD4+. Nutrición Hospitalaria [España] 2013;28:2201-211.

  20. Linares Guerra M, Santana Porbén S. Estado de la adiposidad corporal en sujetos infectados con el virus VIH/sida. RCAN Rev Cubana Aliment Nutr 2016; 26:93-104.

  21. Linares Guerra M. Cambios en el estado nutricional al año de evolución y el recuento absoluto de linfocitos T CD4+ en las personas que viven con VIH/sida. RCAN Rev Cubana Aliment Nutr 2016; 26(2 Supl 1):S1-S93.

  22. Wijk JP, Castro M. Hypertriglyceridemia, metabolic syndrome, and cardiovascular disease in HIV-infected patients: Effects of antiretroviral therapy and adipose tissue distribution. Int J Vasc Med 2012; 2012:2010-2027. Disponible en: https://www.hindawi.com/journals/ijvm/2012/201027/abs/. Fecha de última visita: 12 de Febrero del 2018.

  23. Brown TT, Glesby MJ. Management of the metabolic effects of HIV and HIV drugs. Nat Rev Endocrinol 2011;8:11-21.

  24. Risso GD. Enfermedad cardiovascular en sujetos con VIH/sida. Rev Fed Arg Cardiol 2012;41:235-48. Disponible en: http://www.fac.org.ar/1/revista/12v41n4/art_revis/revis02/risso.php. Fecha de última visita: 12 de Febrero del 2018.

  25. Weiner JS, Lourie JA. Human biology. A guide to field methods. International Biological Program. Handbook number 9. Blackwell Scientific Publications. Oxford: 1969.

  26. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Second Edition. Human Kinetics Books. Champaign [Illinois]: 1991. pp 44-47.

  27. Hannan WJ, Wrate RM, Cowen SJ, Freeman CP. Body mass index as anestimate of body fat. Int J Eating Disorders 1995;18:91-7.

  28. WHO Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bulletin WHO 1986;64:929-41.

  29. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A; et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8.

  30. De León Medrano DL, Muñoz Muñoz MG, Ochoa C. La antropometría en el reconocimiento del riesgo cardio-vascular. RCAN Rev Cubana Aliment Nutr 2017;27:167-88.

  31. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk- A review of the literature. Eur J Clin Nutr 2010;64:16-23.

  32. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010;23: 247-69.

  33. Brooks GA, Butte NF, Rand WM, Flatt JP, Caballero B. Chronicle of the Institute of Medicine physical activity recommendation: How a physical activity recommendation came to be among dietary recommendations. Am J Clin Nutr 2004;79(5 Suppl):S921-S930.

  34. Madrigal Fritsch H, Martínez Salgado H. Manual de Encuestas de Dieta. Serie Perspectivas en Salud Pública. Número 23. Instituto Nacional de Salud Pública. Morelos [México]: 1996.

  35. Institute of Medicine of the National Academies. Food and Nutrition Board: Dietary reference intakes for energy,carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington DC: 2002. Disponible en: http://www.nap.edu/books/0309085373/html/. Fecha de última visita: 3 de Febrero del 2018.

  36. SAS Institute. JMP User's Guide. Versión 3.1. SAS Institute Inc. Cary [North Carolina]: 1997.

  37. Andrade Camacho AB. Manifestaciones dermatológicas del sarcoma de Kaposi en pacientes seropositivos VIH. Estudio realizado en el Hospital de especialidades Dr. Abel Gilbert Pontón durante Enero 2014 a Diciembre 2017. Trabajo de terminación de la carrera de Medicina. Escuela de Medicina. Facultad de Ciencias Médicas. Universidad de Guayaquil. Guayaquil [Ecuador]: 2018. Disponible en: http://repositorio.ug.edu.ec/handle/redug/30643. Fecha de última visita: 16 de Noviembre del 2018.

  38. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A. Obesity among patients with HIV: The latest epidemic. AIDS Patient Care STDs 2008;22: 925-30.

  39. Tate T, Willig AL, Willig JH, Raper JL, Moneyham L, Kempf MC; et al. HIV infection and obesity: Where did all the wasting go? Antiviral Ther 2012;17: 1281-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779137/. Fecha de última visita: 14 de Abril del 2018.

  40. Oliveira OMV, Medeiros RS, Nascimento MABD, De Boni MS. Perfil nutricional e fatores de risco para obesidade central de pessoas que vivem com HIV/AIDS. Comun Ciênc Saúde 2008; 19:305-14. Disponible en: http://www.escs.edu.br/pesquisa/Vol19_4art08.pdf. Fecha de última visita: 14 de Abril del 2018.

  41. Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S; et al.Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PloS One 2012;7(9): e44454-e44454. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0044454. Fecha de última visita: 14 de Mayo del 2018.

  42. Schuelter-Trevisol F, Wolff HF, Alencastro, RP, Grigoletti SL, Ikeda M, Brandao BMA; et al. Physical activity: Do patients infected with HIV practice? How much? A systematic review. Curr HIV Res 2012;10: 487-97.

  43. Jaggers JR, Prasad VK, Dudgeon WD, Blair SN, Sui X, Burgess S, Hand GA. Associations between physical activity and sedentary time on components of metabolic syndrome among adults with HIV. AIDS Care 2014;26:1387-92.

  44. Duran ACFL, Almeida LB, Segurado AAC, Jaime PC. Diet quality of persons living with HIV/AIDS on highly active antiretroviral therapy. J Human Nutr Diet 2008;21:346-50.

  45. Hendricks KM, Mwamburi DM, Newby PK, Wanke CA. Dietary patterns and health and nutrition outcomes in men living with HIV infection. Am J Clin Nutr 2008;88:1584-92.

  46. Grández BB. Estado nutricional y hábitos alimentarios de pacientes con VIH. Rev Peruana Epidemiol 2011; 15:7-12.

  47. Hendricks KM, Willis K, Houser R, Jones CY. Obesity in HIV-infection: Dietary correlates. J Am Coll Nutr 2006; 25:321-31.

  48. Jaime PC, Florindo AA, Latorre MDRDD, Segurado AAC. Central obesity and dietary intake in HIV/AIDS patients. Rev Saúde Pública 2006;40: 634-40.

  49. Batterham MJ, Garsia R, Greenop PA. Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy. The Diet FRS Study. Aids 2000;14:1839-43.

  50. Alves MD, Brites C, Sprinz E. HIV-associated lipodystrophy: A review from a Brazilian perspective. Therap Clin Risk Manag 2014;10:559. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108257/. Fecha de última visita: 14 de Mayo del 2018.

  51. Florindomph AA, Rosario Dias de Oliveira Latorre MD, Jaime PC, Segurado AAC. Leisure time physical activity prevents accumulation of central fat in HIV/AIDS subjects on highly active antiretroviral therapy. Int J STD AIDS 2007;18:692-6.

  52. Leite LHM, Sampaio ABMM. Dietary calcium, dairy food intake and metabolic abnormalities in HIV‐infected individuals. J Human Nutr Diet 2010;23: 535-43.

  53. Haddad L, Gillespie S. Effective food and nutrition policy responses to HIV/AIDS: What we know and what we need to know. J Int Develop 2001;13(4), 487-511. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/jid.799. Fecha de última visita: 16 de Mayo del 2018.




2020     |     www.medigraphic.com